Article

 

NguyenAnhMicrobioDevelopmentConditionalLiver.pdf Public Deposited

Downloadable Content

Download PDF
https://ir.library.oregonstate.edu/concern/articles/mw22v726s

Descriptions

Attribute NameValues
Creator
Abstract
  • Here we report a new transgenic expression system by combination of liver-specific expression, mifepristone induction and Cre-loxP recombination to conditionally control the expression of oncogenic kras[superscript]V12. This transgenic system allowed expression of kras[superscript]V12 specifically in the liver by a brief exposure of mifepristone to induce permanent genomic recombination mediated by the Cre-loxP system. We found that liver tumors were generally induced from multiple foci due to incomplete Cre-loxP recombination, thus mimicking naturally occurring human tumors resulting from one or a few mutated cells and clonal proliferation to form nodules. Similar to our earlier studies by both constitutive and inducible expression of the kras[superscript]V12 oncogene, hepatocellular carcinoma (HCC) is the main type of liver tumor induced by kras[superscript]V12 expression. Moreover, mixed tumors with hepatocellular adenoma and hepatoblastoma (HB) were also frequently observed. Molecular analyses also indicated similar increase of phosphorylated ERK1/2 in all types of liver tumors, but nuclear localization of β–catenin, a sign of malignant transformation, was found only in HCC and HB. Taken together, our new transgenic system reported in this study allows transgenic kras[superscript]V12 expression specifically in the zebrafish liver only by a brief exposure of mifepristone to induce permanent genomic recombination mediated by the Cre-loxP system.
Rights Statement
Additional Information
  • description.provenance : Submitted by Patricia Black (patricia.black@oregonstate.edu) on 2016-02-19T16:00:29Z No. of bitstreams: 3 license_rdf: 1370 bytes, checksum: cd1af5ab51bcc7a5280cf305303530e9 (MD5) NguyenAnhMicrobioDevelopmentConditionalLiver.pdf: 2058398 bytes, checksum: ef0b1eb9009747439ffd9920991d6dd6 (MD5) NguyenAnhMicrobioDevelopmentConditionalLiver(Supplement).pdf: 23883 bytes, checksum: 2134725a67f908fc0cc23d32576714d3 (MD5)
  • description.provenance : Approved for entry into archive by Patricia Black(patricia.black@oregonstate.edu) on 2016-02-19T16:00:58Z (GMT) No. of bitstreams: 3 license_rdf: 1370 bytes, checksum: cd1af5ab51bcc7a5280cf305303530e9 (MD5) NguyenAnhMicrobioDevelopmentConditionalLiver.pdf: 2058398 bytes, checksum: ef0b1eb9009747439ffd9920991d6dd6 (MD5) NguyenAnhMicrobioDevelopmentConditionalLiver(Supplement).pdf: 23883 bytes, checksum: 2134725a67f908fc0cc23d32576714d3 (MD5)
  • description.provenance : Made available in DSpace on 2016-02-19T16:00:58Z (GMT). No. of bitstreams: 3 license_rdf: 1370 bytes, checksum: cd1af5ab51bcc7a5280cf305303530e9 (MD5) NguyenAnhMicrobioDevelopmentConditionalLiver.pdf: 2058398 bytes, checksum: ef0b1eb9009747439ffd9920991d6dd6 (MD5) NguyenAnhMicrobioDevelopmentConditionalLiver(Supplement).pdf: 23883 bytes, checksum: 2134725a67f908fc0cc23d32576714d3 (MD5) Previous issue date: 2016-01-21